Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis

Authors: Kadish, Robert, Clardy, Stacey L., Royston, Minying, Tanvir, Imran, Parker, Tavan, Biskupiak, Joseph, Kielhorn, Adrian

Source: In Journal of Neuroimmunology 15 January 2022 362

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder.

Authors: Berthele, Achim, Levy, Michael, Wingerchuk, Dean M., Pittock, Sean J., Shang, Shulian, Kielhorn, Adrian, Royston, Minying, Sabatella, Guido, Palace, Jacqueline

Source: Frontiers in Neurology; 4/11/2023, Vol. 14, p1-10, 10p

Subject Terms: NEUROMYELITIS optica, QUALITY of life, PEOPLE with disabilities, MENTAL health surveys, DISEASE relapse

Efficacy And Safety Of Bradykinin B2 Receptor Antagonism With Oral Deucrictibant In Prophylaxis Of Hereditary Angioedema Attacks: Results Of CHAPTER-1 Phase 2 Trial

Authors: Riedl, Marc, Anderson, John, Arcoleo, Francesco, Cancian, Mauro, Chapdelaine, Hugo, Conlon, Niall, Eren, Efrem, Gompels, Mark, Grigoriadou, Sofia, Guarino, Maria, Gurugama, Padmalal, Kinaciyan, Tamar, Magerl, Markus, Manning, Michael, Stobiecki, Marcin, Tarzi, Michael, Valerieva, Anna, Wedner, H. James, Yang, William, Zanichelli, Andrea, Crabbe, Rafael, Mulders, Susan, Royston, Minying, Zhu, Li, Knolle, Jochen, Lesage, Anne, Lu, Peng, Aygören-Pürsün, Emel

Source: In The Journal of Allergy and Clinical Immunology February 2024 153(2) Supplement:AB11-AB11

A Response to: Letter to the Editor Regarding "Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder".

Authors: Wingerchuk, Dean M., Zhang, Ina, Kielhorn, Adrian, Royston, Minying, Levy, Michael, Fujihara, Kazuo, Nakashima, Ichiro, Tanvir, Imran, Paul, Friedemann, Pittock, Sean J.

Source: Neurology & Therapy; Sep2022, Vol. 11 Issue 3, p1445-1449, 5p

Subject Terms: NEUROMYELITIS optica, AQUAPORINS, ADULTS

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder.

Authors: Wingerchuk, Dean M., Zhang, Ina, Kielhorn, Adrian, Royston, Minying, Levy, Michael, Fujihara, Kazuo, Nakashima, Ichiro, Tanvir, Imran, Paul, Friedemann, Pittock, Sean J.

Source: Neurology & Therapy; Mar2022, Vol. 11 Issue 1, p123-135, 13p

Subject Terms: NEUROMYELITIS optica, AQUAPORINS, ADULTS, CENTRAL nervous system, IMMUNOSUPPRESSIVE agents, BAYESIAN analysis

Company/Entity: UNITED States. Food & Drug Administration

Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice.

Authors: Royston, Minying¹ (AUTHOR), Kielhorn, Adrian¹ (AUTHOR), Weycker, Derek² (AUTHOR) dweycker@pai2.com, Shaff, Melody² (AUTHOR), Houde, Linnea² (AUTHOR), Tanvir, Imran¹ (AUTHOR), Bhattacharyya, Shamik^3,4 (AUTHOR), Levy, Michael^4,5 (AUTHOR)

Source: Neurology & Therapy. Dec2021, Vol. 10 Issue 2, p767-783. 17p.

Subject Terms: *NEUROMYELITIS optica, *DISEASE relapse, *MEDICAL offices, *INPATIENT care, *SPINAL nerves, *HEALTH insurance, *PHYSICIAN services utilization

(QOL02) The Impact of Relapses on Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder: Data from the Phase 3 PREVENT Study.

Authors: Berthele, Achim, Levy, Michael, Johnston, Karissa, Harwood, Meagan, Kielhorn, Adrian, Royston, Minying, Sabatella, Guido, Palace, Jacqueline

Source: International Journal of MS Care; 2020, Vol. 22 Issue S2, p63-64, 2p

Subject Terms: AUTISM, CONFERENCES & conventions, QUALITY of life, DISEASE relapse, NEUROMYELITIS optica